title: Plasminogen activator inhibitor-1 and the risk of Type 2 diabetes mellitus in American Indians: the Strong Heart Study.
authors.forename: M
authors.initials: M
authors.lastname: Davidson
authors.forename: J
authors.initials: J
authors.lastname: Zhu
authors.forename: W
authors.initials: W
authors.lastname: Lu
authors.forename: R P
authors.initials: RP
authors.lastname: Tracy
authors.forename: D C
authors.initials: DC
authors.lastname: Robbins
authors.forename: H E
authors.initials: HE
authors.lastname: Resnick
authors.forename: G
authors.initials: G
authors.lastname: Ruotolo
authors.forename: B V
authors.initials: BV
authors.lastname: Howard
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis*; D003925:Diabetic Angiopathies / Q000175:diagnosis*; D006801:Humans; D007198:Indians, North American; D007333:Insulin Resistance; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism*; D018570:Risk Assessment; D012307:Risk Factors; D015842:Serine Proteinase Inhibitors
chemical_list: D017395:Plasminogen Activator Inhibitor 1; D015842:Serine Proteinase Inhibitors